Microbiome as therapeutics in vesicular delivery

Singhvi, G; Girdhar, V; Patil, S; Gupta, G; Hansbro, PM; Dua, K

Microbiome as therapeutics in vesicular delivery

Singhvi, G Girdhar, V Patil, S Gupta, G Hansbro, PM

Dua, K

Permalink

Publication Type:: Journal Article
Citation:: Biomedicine and Pharmacotherapy, 2018, 104 pp. 738 - 741
Issue Date:: 2018-08-01

Closed Access

	Filename	Description	Size
	1-s2.0-S0753332218329433-main.pdf	Published Version	685.7 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Singhvi, G	en_US
dc.contributor.author	Girdhar, V	en_US
dc.contributor.author	Patil, S	en_US
dc.contributor.author	Gupta, G	en_US
dc.contributor.author	Hansbro, PM https://orcid.org/0000-0002-4741-3035	en_US
dc.contributor.author	Dua, K https://orcid.org/0000-0002-7507-1159	en_US
dc.date.available	2018-05-21	en_US
dc.date.issued	2018-08-01	en_US
dc.identifier.citation	Biomedicine and Pharmacotherapy, 2018, 104 pp. 738 - 741	en_US
dc.identifier.issn	0753-3322	en_US
dc.identifier.uri	http://hdl.handle.net/10453/128316
dc.description.abstract	© 2018 Elsevier Masson SAS Microbiome refers to an ecological community of various symbiotic and pathogenic microorganisms, which plays a crucial role in human health and disease. The concept of novel drug delivery systems particularly the vesicular drug delivery systems is gaining massive attention. This emerging technology has started expanding its horizons in the area of microbiome delivery. This mini-review highlights the role of vesicular systems such as nanoparticles, liposomes etc. as a host/carrier for the microbiome in targeting various diseases. This review will be of interest for both the biological and formulation scientists to understand and explore the new vistas in the area of vesicular delivery system as carrier for microbiome delivery.	en_US
dc.relation.ispartof	Biomedicine and Pharmacotherapy	en_US
dc.relation.isbasedon	10.1016/j.biopha.2018.05.099	en_US
dc.subject.classification	Oncology & Carcinogenesis	en_US
dc.subject.mesh	Animals	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Liposomes	en_US
dc.subject.mesh	Drug Carriers	en_US
dc.subject.mesh	Drug Delivery Systems	en_US
dc.subject.mesh	Chemistry, Pharmaceutical	en_US
dc.subject.mesh	Nanoparticles	en_US
dc.subject.mesh	Microbiota	en_US
dc.title	Microbiome as therapeutics in vesicular delivery	en_US
dc.type	Journal Article
utslib.citation.volume	104	en_US
utslib.for	1115 Pharmacology and Pharmaceutical Sciences	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
pubs.organisational-group	/University of Technology Sydney/Faculty of Science/School of Life Sciences
pubs.organisational-group	/University of Technology Sydney/Graduate School of Health
utslib.copyright.status	closed_access
pubs.publication-status	Published	en_US
pubs.volume	104	en_US

Abstract:

© 2018 Elsevier Masson SAS Microbiome refers to an ecological community of various symbiotic and pathogenic microorganisms, which plays a crucial role in human health and disease. The concept of novel drug delivery systems particularly the vesicular drug delivery systems is gaining massive attention. This emerging technology has started expanding its horizons in the area of microbiome delivery. This mini-review highlights the role of vesicular systems such as nanoparticles, liposomes etc. as a host/carrier for the microbiome in targeting various diseases. This review will be of interest for both the biological and formulation scientists to understand and explore the new vistas in the area of vesicular delivery system as carrier for microbiome delivery.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/128316